We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Reckitt Benckiser Group Plc | LSE:RB. | London | Ordinary Share | GB00B24CGK77 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6,498.00 | 6,502.00 | 6,506.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
--GlaxoSmithKline (GSK), which is looking to sell its consumer healthcare business in India, has drawn bids from Nestle S.A (NSRGY), Unilever N.V. (UN) and Coca-Cola Co. (KO), Reuters reported Tuesday, citing "four people familiar with the mater."
--The sale of a 72.5% stake in its GlaxoSmithKline Consumer Healthcare is expected to bring in more than $4 billion, the report said.
--An offer was not made by Reckitt Benckiser Group PLC (RBGLY), although it is looking to strengthen its consumer health operation, the report said.
--The consumer healthcare business makes such products as malt beverage Horlicks and chocolate malt drink Boost, the report said.
Full story: https://www.reuters.com/article/us-gsk-m-a-india-exclusive/exclusive-nestle-unilever-coke-make-bids-in-4-billion-plus-gsk-india-sale-sources-idUSKCN1LY2GT
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 18, 2018 14:17 ET (18:17 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Reckitt Benckiser Chart |
1 Month Reckitt Benckiser Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
